‘The Question Is, What’s Going To Happen Next?’ – The Future For Biosimilars In Europe

Isabell Remus And Julie Maréchal-Jamil Discuss Next Steps

 
• By Dave Wallace
  
The latest developments cast Europe’s biosimilars industry in a fresh light (Shutterstock)

More from Biosimilars & Generics

More from Agency Leadership